Using a Geriatric Oncology Assessment to Link With Services

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-31

Study Completion Date

2017-09-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to implement a brief geriatric oncology assessment (GOA) in a community-based oncology clinic, the Scotland Cancer Treatment Center - a clinic within the Duke Cancer Network, located in the rural, low resource Scotland County community of North Carolina. Secondly, the investigators will evaluate the effectiveness of the brief GOA by comparing historical and post-GOA service referral patterns and adherence to planned cancer therapy. For this study, the investigators will prospectively enroll up to 60 patients who have been diagnosed and/or treated for cancer to complete the brief GOA. In addition to these 60 patients, the investigators will also conduct retrospective chart reviews on 120 patients that would be eligible for this study to evaluate past referral patterns. Eligible and consented patients will complete the brief GOA at the Scotland Cancer Treatment Center alongside their normal clinic appointment. The investigators will assess impact on the healthcare system by evaluating referral patterns (i.e., how many, what type of services) using the brief GOA data and EHR data. The study value includes the possibility for recognition and access to additional health care referrals if needed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Registry of Older Patients With Cancer

NCT01137825

Chronic Myeloproliferative Disorders Cognitive/Functional Effects Leukemia +6 more

RECRUITING

Increasing Germline Genetic Testing for Patients With Cancer

NCT07307664

Hereditary Pancreatic Cancer Conditions or Focus of Study Hereditary Breast Cancer +1 more

NOT_YET_RECRUITING NA

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

Breast Cancer, NOS CNS Primary Tumor, NOS Cervical Cancer, NOS +9 more

RECRUITING NA

HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598

NCT00896909

Lung Cancer

COMPLETED

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

NCT04902144

Breast Carcinoma Colon Carcinoma Malignant Solid Neoplasm +3 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to be included in the project, patients must be:

1. Diagnosed for a solid tumor cancer (breast, lung, colon, rectal, colorectal (unspecified), pancreas, esophageal)
2. Diagnosis date within 12 months of identification
3. Receiving care at Scotland Cancer Treatment Center
4. Aged 60 years or older at the time of the visit
5. Planned therapy in the medical oncology clinic at the Scotland Cancer Treatment Center

Exclusion Criteria

1. Diagnosis of metastatic cancer with \<12 months life expectancy
2. Planned cancer therapy as surgery only
3. Receiving palliative or hospice care services (i.e., proxy for \<12 months life expectancy)
4. Language (not proficient in English)
5. Nursing home/long-term care facility resident
6. Active diagnosis of psychosis (has been hospitalized in the last 30 days), schizophrenia, severe intellectual or developmental disabilities, or dementia
7. Patient deemed not fit/good candidate for study per provider recommendation

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No